PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Sees Significant Decline in Short Interest

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) saw a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 8,311 shares, a decrease of 83.9% from the May 14th total of 51,769 shares. Based on an average trading volume of 266,185 shares, the days-to-cover ratio is currently 0.0 days.

PharmaTher Stock Performance

OTCMKTS:PHRRF traded up $0.00 on Thursday, hitting $0.04. 94,000 shares of the stock were exchanged, compared to its average volume of 175,821. The stock has a fifty day moving average of $0.05 and a 200-day moving average of $0.06. PharmaTher has a fifty-two week low of $0.04 and a fifty-two week high of $0.55.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.